Analysis of Behavioral Factors on Medications in Gout Patients with Health belief Model Theory
Abstract
Keywords : Adherence, Health Belief Model, Gout, Community Health Center, Behavior
Full Text:
PDFReferences
Dipiro J, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy Handbook 9th Edition. 9th editio. (Education M-H, ed.). United States: McGraw-Hill Education; 2014.
FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res. 2020;72(6):744-760. doi:10.1002/acr.24180
Kuo CF, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: Prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015;11(11):649-662. doi:10.1038/nrrheum.2015.91
Widyanto WF. Artritis Gout Dan Perkembangannya. Saintika Med. 2017;10(2):145. doi:10.22219/sm.v10i2.4182
Riskesdas K. Hasil Utama Riset Kesehatan Dasar (RISKESDAS). Vol 44. Jakarta; 2018. https://www.kemkes.go.id/resources/download/info-terkini/hasil-riskesdas-2018.pdf.
Dinas Kesehatan Kota Malang. Laporan Kasus Asam Urat Di Kota Malang Tahun 2019. Malang; 2019.
Li Q, Li X, Wang J, et al. Diagnosis and treatment for hyperuricemia and gout: A systematic review of clinical practice guidelines and consensus statements. BMJ Open. 2019;9(8):1-13. doi:10.1136/bmjopen-2018-026677
Rothschild BM. Gout and Pseudogout. Medscape. https://emedicine.medscape.com/article/329958-overview. Published 2019.
Reach G, Chenuc G, Maigret P, Elias-Billon I, Martinez L, Flipo RM. Implication of character traits in adherence to treatment in people with gout: A reason for considering nonadherence as a syndrome. Patient Prefer Adherence. 2019;13:1913-1926. doi:10.2147/PPA.S227329
Perez-Ruiz F, Desideri G. Improving adherence to gout therapy: An expert review. Ther Clin Risk Manag. 2018;14:793-802. doi:10.2147/TCRM.S162956
Scheepers LEJM, Burden AM, Arts ICW, et al. Medication adherence among gout patients initiated allopurinol: A retrospective cohort study in the Clinical Practice Research Datalink (CPRD). Rheumatol (United Kingdom). 2018;57(9):1641-1650. doi:10.1093/rheumatology/key155
Conner M, Norman P. Health Behavior. In: Comprehensive Clinical Psychology. ; 1998:1-37. doi:10.4324/9781315732947-11
Jeihooni AK, Hidarnia A, Kaveh MH, Hajizadeh E, Askari A. The effect of an educational program based on health belief model on preventing osteoporosis in women. Int J Prev Med. 2015;2015(November). doi:10.4103/2008-7802.170429
Glanz K, Rimer barbara k., Viswanath K. Health Behavior and Health Education : Theory, Research, and Practice. 4th editio. United States of America: John Wiley & Sons, Inc.; 2008.
Li Y, Piranavan P, Sundaresan D, Yood R. Clinical Characteristics of Earlyâ€Onset Gout in Outpatient Setting. ACR Open Rheumatol. 2019;1(7):397-402. doi:10.1002/acr2.11057
Martini N, Bryant L, Karu L Te, et al. Living with gout in New Zealand: An exploratory study into People’s knowledge about the disease and its treatment. J Clin Rheumatol. 2012;18(3):125-129. doi:10.1097/RHU.0b013e31824e1f6f
Zandman-Goddard G, Amital H, Shamrayevsky N, Raz R, Shalev V, Chodick G. Rates of adherence and persistence with allopurinol therapy among gout patients in Israel. Rheumatol (United Kingdom). 2013;52(6):1126-1131. doi:10.1093/rheumatology/kes431
Sheng F, Fang W, Zhang B, Sha Y, Zeng X. Adherence to gout management recommendations of Chinese patients. Med (United States). 2017;96(45):1-6. doi:10.1097/MD.0000000000008532
Spaetgens B, Pustjens T, Scheepers LEJM, Janssens HJEM, van der Linden S, Boonen A. Knowledge, illness perceptions and stated clinical practice behaviour in management of gout: a mixed methods study in general practice. Clin Rheumatol. 2016;35(8):2053-2061. doi:10.1007/s10067-016-3212-2
Singh JA. Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: A qualitative study. Arthritis Res Ther. 2014;16(2):1-13. doi:10.1186/ar4524
Shao C, Wang J, Liu J, Tian F, Li H. Effect of a health belief model-based education program on patients’ belief, physical activity, and serum uric acid: A randomized controlled trial. Patient Prefer Adherence. 2018;12:1239-1245. doi:10.2147/PPA.S166523
Venkatachalam J, Abrahm S, Singh Z, Stalin P, Sathya G. Determinants of patient′s adherence to hypertension medications in a rural population of Kancheepuram District in Tamil Nadu, South India. Indian J Community Med. 2015;40(1):33-37. doi:10.4103/0970-0218.149267
Ayele K, Tesfa B, Abebe L, Tilahun T, Girma E. Self care behavior among patients with diabetes in harari, eastern ethiopia: The health belief model perspective. PLoS One. 2012;7(4). doi:10.1371/journal.pone.0035515
Kamran A, Sadeghieh Ahari S, Biria M, Malepour A HH. Determinants of Patient’s Adherence to Hypertension Medications: Application of Health Belief Model Among Rural Patients. Ann Med Heal Sci Res. 2014;4(6):922-927. doi:doi:10.4103/2141-9248.144914
Harvey JN, Lawson VL. The importance of health belief models in determining self-care behaviour in diabetes. Diabet Med. 2009;26(1):5-13. doi:10.1111/j.1464-5491.2008.02628.x
Shojaei S, Farhadloo R, Aein A, Vahedian M. Effects of the Health Belief Model (HBM)-based educational program on the nutritional knowledge and behaviors of CABG patients. J Tehran Univ Hear Cent. 2016;11(4):181-186.
Chan AHY, Cooper V, Lycett H, Horne R. Practical Barriers to Medication Adherence: What Do Current Self- or Observer-Reported Instruments Assess? Front Pharmacol. 2020;11(May):1-11. doi:10.3389/fphar.2020.00572
Singh JA, Herbey I, Bharat A, et al. Gout Self-Management in African American Veterans: A Qualitative Exploration of Challenges and Solutions From Patients’ Perspectives. Arthritis Care Res. 2017;69(11):1724-1732. doi:10.1002/acr.23202
Refbacks
- There are currently no refbacks.